产品中心 抗体 其他一抗

所有图片(1/3)

BTLA/CD272 Recombinant Rabbit mAb (S-742-13)

B- and T-lymphocyte attenuator,B- and T-lymphocyte-associated protein

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B0668
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 分子别名

    B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Cell membrane
  • Accession

    Q7TSA3
  • 克隆号

    S-742-13
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Ms, Rt
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    IHC-P ?

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Ms, Rt
    IHC-P 1:500 Ms
背景介绍
  • CD272, also known as B and T lymphocyte attenuator (BTLA), is an antigen closely related to immune cell function. When the body is stimulated by antigenic substances, B-cells differentiate into plasma cells, producing immunoglobulins that can specifically bind to the corresponding antigens. CD272, as the B and T lymphocyte attenuator antigen, may play an important role in this process. In recent years, the application of CD272 in medical research has gradually increased. For example, in studies of acute myeloid leukemia, scientists have discovered that leukemia stem cells highly express CD272, and its high expression is negatively correlated with poor prognosis and survival rates of patients. This discovery provides a new target and research idea for the treatment of leukemia. By blocking the cross-linking signal between CD272 and its ligand, the growth of leukemia cells can be effectively inhibited, providing new possibilities for the treatment of leukemia.

  • 免疫印迹

    • WB result of BTLA/CD272 Rabbit mAb
      Primary antibody: BTLA/CD272 Rabbit mAb at 1/1000 dilution
      Lane 1: A20 whole cell lysate 20 µg
      Lane 2: mouse spleen lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 34 kDa
      Observed MW: 45~70 kDa

    • WB result of BTLA/CD272 Rabbit mAb
      Primary antibody: BTLA/CD272 Rabbit mAb at 1/1000 dilution
      Lane 1: rat spleen lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 34 kDa
      Observed MW: 55~70 kDa

  • 免疫组化

    • IHC shows positive staining in paraffin-embedded mouse spleen. Anti- BTLA/CD272 antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)